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Abstract
The aim of this study was to fabricate mechanically functional microsphere-based scaffolds 
containing decellularized cartilage (DCC), with the hypothesis that this approach would induce 
chondrogenesis of rat bone marrow-derived mesenchymal stem cells (rBMSCs) in vitro. The DCC 
was derived from porcine articular cartilage and decellularized using a combination of physical 
and chemical methods. Four types of scaffolds were fabricated: Poly(D,L-lactic-co-glycolic acid) 
(PLGA) only (negative control), TGF-β encapsulated (positive control), PLGA surface coated with 
DCC, and DCC-encapsulated. These scaffolds were seeded with rBMSCs and cultured up to 6 
weeks. The compressive modulus of the DCC-coated scaffolds prior to cell seeding was 
significantly lower than all other scaffold types. Gene expression was comparable between DCC-
encapsulated and TGF-β encapsulated groups. Notably, DCC-encapsulated scaffolds contained 
70% higher glycosaminoglyan (GAG) content and 85% more hydroxyproline compared to the 
TGF-β group at week 3 (with baseline levels subtracted out from acellular DCC scaffolds). 
Certainly bioactivity was demonstrated in eliciting a biosynthetic response from the cells with 
DCC, although true demonstration of chondrogenesis remained elusive under the prescribed 
conditions. Encapsulation of DCC appeared to lead to improved cell performance relative to 
coating with DCC, although this finding may be a dose-dependent observation. Overall, DCC 
introduced via microsphere-based scaffolds appears to be promising as a bioactive approach to 
cartilage regeneration, although additional studies will be required to conclusively demonstrate 
chondroinductivity.
Introduction
Articular cartilage has limited capability for self repair after traumatic injury or 
osteoarthritis. Self-repair is limited in part because of the dense extracellular matrix (ECM), 
sparse chondrocyte population, and reduced access to systemic circulation. Current clinical 
treatments include osteochondral transplantation (mosaicplasty), autologous chondrocyte 
implantation (ACI), and microfracture.1, 15 These current treatment options may produce 
inferior repair cartilage with respect to mechanical performance, tissue reintegration, and 
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composition.6, 22 They also have additional associated risks such as donor site morbidity and 
the need for multiple surgical procedures. Recently, acellular biomaterials have gained much 
popularity in the tissue engineering field due to the potential to create an off-the-shelf 
product with characteristics that aid in repairing cartilage tissue by enhancing stem cell 
recruitment, infiltration, and differentiation.2, 5 One such material in particular, 
decellularized cartilage (DCC),33 may be beneficial as it contains similar biochemical 
content as native cartilage and current problems associated with allograft implants (i.e., long 
term storage and immunogenicity) are mitigated.4, 21, 23, 29 Previous studies have reported 
adipose derived stem cell (ASC) and bone marrow-derived mesenchymal stem cell (BMSC) 
differentiation in the presence of DCC.6, 7, 34
One challenge with DCC-based scaffolds is that the mechanical function of the scaffolds 
may be compromised during the decellularization process.22, 28, 29 To help fabricate a 
material with a compressive strength suitable for articular cartilage repair, combining DCC 
with a polymeric scaffold has previously been shown to achieve greater mechanical 
performance than DCC scaffolds alone.27 Using cartilage matrix to coat polymeric based 
scaffolds has also been investigated previously with electrospun scaffolds, but instead of 
using native cartilage, cell-derived cartilage matrix (CDM) secreted in vitro was used.24
We recently defined categories of cartilage matrix for tissue engineering in Advanced 
Healthcare Materials.33 The difference between native DCC and CDM in particular must be 
emphasized here, as these matrices may vary in both composition and mechanical 
performance. Decellularization efficiency may be greater in CDM because the matrix is less 
dense, but the material may not contain the same composition as native cartilage ECM that 
comprises DCC. DCC was chosen for use in this study for the ease of acquiring the material 
and the ability to efficiently decellularize the tissue while maintaining biochemical content 
similar to native cartilage ECM.
Microsphere-based scaffolds for osteochondral tissue engineering are an attractive delivery 
vehicle for DCC due to the ability to control the morphology of the microspheres and, in 
turn, the properties of the bulk scaffold.11, 26 The polymeric material can also be selected for 
desired degradation and release rates of a wide variety of encapsulated materials.8, 17, 18, 32 
Previously, chondroitin sulfate and bioactive glass as “raw materials” have been 
encapsulated in poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres that aided in BMSC 
differentiation and proliferation.26 DCC, however, has never previously been incorporated 
into microsphere-based scaffolds.
In the present study, we investigated the encapsulation of DCC in PLGA microsphere-based 
scaffolds and the coating of the surface of PLGA microsphere scaffolds. Our hypothesis was 
that the DCC material would aid in chondrogenic differentiation of BMSCs in vitro.
Materials and Methods
Materials
All reagents for decellularization were purchased from Sigma Aldrich (St. Louis, MO) 
unless otherwise noted. PLGA (50:50 D, L-PLGA with acid end group, intrinsic viscosity 
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0.40-0.50 dL/g) was purchased from Lakeshore Biomaterials (Birmingham, AL). Human 
recombinant TGF-β3 was purchased from PeproTech (Rocky Hill, NJ). 10 porcine knee and 
hip joints were obtained from crossbreed hogs (Cheshire White, Yorkshire, Berkshire, 
Duroc, Landrace, and Hampshire) with an approximate average mass of 120 kg. The joints 
were purchased from a local abattoir following sacrifice (Bichelmeyer Meats, Kansas City, 
KS).
Tissue Harvest and Decellularization
Articular cartilage was collected from joint surfaces using scalpels and immediately rinsed 
in phosphate buffered saline (PBS). No arthritic lesions were noted in joints from which the 
cartilage was collected. PBS was drained from the material and cartilage was stored at 
−20°C until further use. Decellularization of the cartilage was performed using a protocol 
adapted from Converse et al.9 The cartilage was first coarsely ground using a cryogenic 
tissue grinder to reduce diffusion distances during the decellularization process (BioSpec 
Products, Bartlesville, OK). Following additional freezing at −20°C, the cartilage particles 
were packaged into dialysis tubing (3500 MWCO) and stored in hypertonic salt solution 
(HSS) overnight at 21°C with gentle shaking (70 rpm). All subsequent steps were performed 
at 21°C under agitation (200 rpm) unless otherwise noted. The tissue was then subject to two 
reciprocating washes of triton X-100 (0.01% v/v) followed with HSS to permeabilize intact 
cellular membranes. Overnight, the tissue was treated with benzonase (0.0625 KU ml-1) to 
fragment nucleic acids at 37°C. Next, the tissue was treated with sodium-lauroylsarcosine 
(NLS, 1% v/v) overnight to further lyse cells and denature cellular proteins. Following NLS, 
the tissue was washed with ethanol (40% v/v). The tissue was then subjected to organic 
exchange resins to extract the organic solvents. Lastly, the tissue was washed in saline-
mannitol solution (SMS). Following decellularization, the cartilage tissue was rinsed with 
deionized water and stored at −20°C. After freezing, the tissue was lyophilized and cryo-
ground in a freezer-mill (SPEX Sample Prep, Metuchen, NJ).
Microsphere and Scaffold Fabrication
Three types of microspheres were produced (1) PLGA only (PLGA) (negative control), (2) 
TGF-β3 encapsulated (TGF) (positive control), and (3) solubilized DCC encapsulated (DCC-
encapsulated). All microspheres were fabricated using the patented precision particle 
formation method.3, 12, 26, 32 Microspheres were approximately 350-400 μm in diameter.
PLGA microspheres were fabricated at 20% w/v. DCC microspheres were fabricated by first 
solubilizing the DCC in an acid-pepsin solution for 24 hours. The acid pepsin solution 
contained 0.1 M HCl, 20 mg DCC / 1 mL HCl, and 1 mg pepsin / 1 mL HCl (pH = 5) 
(Sigma Aldrich, St. Louis, MO). After the solubilization period, the pH of the solution was 
raised by adding one-tenth the solubilized solution volume of 1 M NaOH and one-tenth the 
final solution volume of 10x PBS (pH = 8).30 The solubilized solution was then frozen and 
lyophilized. The solubilized DCC was added to a PLGA solution at 10% w/w. TGF-β was 
reconstituted in 10 mM citric acid TGF microspheres were created with a concentration of 
30 μg TGF-β3/ g PLGA.12, 26
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Scaffolds were fabricated as previously described.13, 26, 32 Briefly, microspheres were first 
loaded in a glass cylindrical mold. A 10 μm filter was used at the bottom of the mold and DI 
H2O was pulled through the mold by a vacuum pump. The microspheres were sintered 
together in a 95% v/v ethanol-acetone solution for 45 minutes. Resulting scaffold 
dimensions were an average height of 4.43 ± .99 mm and an average diameter of 3.75 ± .08 
mm. DCC-coated PLGA scaffolds were created using PLGA scaffolds (from PLGA-only 
microspheres; creating a DCC-coated group). The PLGA scaffolds were placed in the DCC 
acid-pepsin solution for 3 minutes and the pH was adjusted to neutral by adding 1 M NaOH. 
The scaffolds were then lyophilized. Following sintering, the scaffolds were lyophilized. All 
scaffolds were sterilized with ethylene oxide prior to cell seeding. Additionally, additional 
acid-treated scaffolds were created specifically for mechanical testing purposes. PLGA 
scaffolds were exposed to an acidic HCl solution (pH = 5) for 3 minutes and then 
lyophilized to mimic the effects of the acid-pepsin solution to which the scaffolds were 
exposed during the DCC-coating process.
Cell Isolation and Culture
Following a University of Kansas approved IACUC protocol (AUS 175-08), BMSCs were 
isolated from the femurs of 4 male Sprague-Dawley rats (200-250 g). Cells were isolated 
from the femurs by flushing the bones with cell culture media and immediately transferring 
the isolated bone marrow to tissue culture flasks. During expansion, the BMSCs were 
cultured in minimum essential media (MEM) alpha with 10% fetal bovine serum (FBS) and 
1% antibiotic-antimycotic. The BMSCs were expanded to passage 4 and suspended in cell 
culture media at a concentration of 12 × 105 cells/mL and 40 μL of cell suspension was 
pipetted onto constructs at 1 × 107 cells/cm3 (500,000 cells/scaffold). After cells were 
seeded in the scaffolds, the scaffolds were placed in the incubator for 1 hour to allow the 
cells to attach before adding culture media. The cell seeded scaffolds were cultured in 
medium containing high glucose DMEM, 1% insulin-transferrin-selenium 100X (ITS), 50 
μg/mL ascorbic acid, 40 μg/mL L-proline, 1% penicillin-streptomycin, 0.1 μM 
dexamethasone, 25 mM HEPES buffer, 1% non-essential amino acids (NEAA), and 100 μM 
sodium pyruvate.
SEM Imaging and Energy Dispersion Spectroscopy
Microspheres were imaged with a LEO 1550 scanning electron microscope (SEM) to 
observe the morphology of the microsphere surfaces. All microspheres were sputter-coated 
with 15 nm gold. To visualize the distribution of DCC, the presence of atomic nitrogen on 
the surface of the DCC-encapsulated microspheres was detected by SEM using energy 
dispersive spectroscopy (EDS) at 10 kV.
Biochemical Content Analysis
Biochemical content analysis was performed on solubilized DCC, acellular scaffolds, and 
cell seeded scaffolds (n = 5). For all analyses day 0 samples were collected at 24 hours. The 
biochemical content of the cell-seeded scaffolds was measured at 0, 3, and 6 weeks. 
Acellular scaffolds matched each time point and were used to subtract base values for all 
biochemical content. All samples were digested in 1 mL of papain solution containing 125 
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μg/mL papain, 5mM N-acetyl cysteine, 5mM ethylenediaminetetraacetic acid (EDTA), and 
100 mM PBS.13, 16, 32
Biochemical content was measured as previously described.13, 16, 32 Briefly, double stranded 
DNA content was measured with the PicoGreen assay (Molecular Probes, Eugene, OR). The 
assay was performed according to the manufacture's instructions. Sulfated 
glycosaminoglycan (GAG) content was measured with the dimethylmethylene blue 
(DMMB) assay (Blyscan, Westbury, NY) according to the manufacturer protocol. Total 
hydroxyproline content was measured with the Sigma-Aldrich commercially available 
hydroxyproline assay kit (St. Louis, MO).
DCC Release Analysis
Acellular DCC-encapsulated and DCC-coated were cultured in the same conditions as cell 
seeded scaffolds. The scaffolds were used to determine the remaining amount of GAG and 
hydroxyproline as described above. The amount of GAG and hydroxyproline content in 
acellular scaffolds was used to approximate the release of the DCC from the scaffolds.
Mechanical Testing
Uniaxial unconfined compression testing was performed on acellular scaffolds (n=4-5) with 
a custom-built compression-bath assembly in an Instron 5848 microtester (Norwood, 
MA).31 Five different scaffold groups were tested: PLGA, TGF, DCC-coated, DCC-
encapsulated, and acid treated scaffolds. Following a tare load of 0.01 N, samples were 
compressed at a strain rate of 10%/min in PBS at 37 °C. The compressive modulus was 
calculated from the linear region of the stress-strain curve.
Gene Expression Analysis
Gene expression analysis was performed at 0, 1.5, 3, and 6 weeks (n=5). Day 0 was defined 
as 24 hours following cell seeding. RNA was isolated and purified with the Qiagen 
(Valencia, CA) RNeasy kit following manufacturer recommendations. RNA was reverse-
transcribed using a high capacity reverse transcriptase kit (Invitrogen, Carlsbad, CA). RT-
PCR was performed with a RealPlex thermocycler (Eppendorf, Hauppauge, NY) and 
TaqMan gene expression assays (Invitrogen, Carlsbad, CA). All primers were commercially 
available and purchased from Invitrogen. Gene expression analysis was performed for both 
chondrogenic and osteogenic gene markers including Coll1A1, Coll2A1, Aggrecan, Sox9, 
and Runx2. GAPDH was used as an endogenous control. All results are reported as relative 
expression to GAPDH using the 2-ΔΔCt method.13, 25
Immunohistochemical Staining
Immunohistochemistry was performed on week 3 DCC-encapsulated scaffolds. Week 6 
constructs did not withstand the initial processing and were not suitable for IHC use. The 
scaffolds were fixed in 10% formalin and embedded in optimal cutting temperature (OCT) 
medium (Tissue-Tek, Torrance, CA). 10 μm thick sections were cut using a cryostat (Micron 
Hm-500 OMP, Vista, CA). Primary antibodies for collagen I, collagen II, and aggrecan were 
obtained from Abcam (Cambridge, MA). Following the primary antibodies, biotinylated 
secondary antibodies were used followed with the ABC complex (Vector Labratories, 
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Burlingame, CA). The antibodies were visualized with the diaminobenzidine (DAB) 
substrate per the manufacturer's protocol. Acellular scaffolds were also stained to provide 
background staining levels for the DCC-containing scaffolds.
Statistical Analysis
All results are reported as mean ± standard deviation. Box plots were created to remove all 
statistical outliers. Statistical analyses were performed using one way analysis of variance 
(ANOVA) and Tukey's post-hoc tests. Significance was reported for p<0.05. SPSS statistical 
software was used for all analyses (Armonk, NY).
Results
Microsphere Morphology
PLGA microspheres had a smooth, even surface without any pores (Fig. 1). TGF 
microspheres showed small pores on the surfaces. The DCC microspheres also had 
numerous small pores on the surface. To view the distribution of DCC, EDS showed that 
atomic nitrogen was present on the surface of the DCC-encapsulated microspheres (Fig. 2), 
and that the nitrogen was fairly evenly distributed, although not perfectly uniform.
Tissue Decellularization
Following decellularization and cryo-grinding the DNA content was reduced by 86%. The 
GAG content was reduced by 55% and the hydroxyproline content was not significantly 
changed (results not shown).
Biochemical Analysis
Dry SDCC contained 42.6 ± 2.6 μg GAG/mg prior to incorporation into scaffolds. Acellular 
scaffolds were used to determine the remaining GAG and hydroxyproline content in the 
DCC and coated scaffolds. At t = 0, the acellular DCC-encapsulated scaffolds contained 
nearly 4 times as much GAG as the acellular DCC-coated scaffolds (p<0.001) (Fig. 3). The 
acellular DCC-encapsulated group showed an approximately 50% decrease in GAG content 
from day 0 to week 3 (p<0.001) (Fig. 3). After week 3, the GAG content remained roughly 
equal through week 6 in DCC-encapsulated scaffolds (no significant difference). The 
hydroxyproline content in the DCC-encapsulated scaffolds was approximately 10 times 
greater than in the DCC-coated group at day 0 (p<0.001). The DCC-encapsulated scaffold 
hydroxyproline content remained similar between weeks 3 and 6. Relative GAG loss in both 
DCC-encapsulated and DCC-coated scaffolds was similar by week 6 (Fig. 4).
Moving on to the cell-seeded scaffolds, at day 0 (24 hours after seeding), the cell-seeded 
DCC-coated scaffold group had approximately 30% more DNA than all of the other groups 
at all times (p<0.001) (Fig. 5). By week 3, all of the groups had similar amounts of DNA 
and remained constant through week 6 at approximately 3.5 μg DNA/scaffold. Since there 
were no statistically significant differences in DNA content among groups, other than the 
day 0 DCC-coated group, the hydroxyproline and GAG totals are reported here on a basis of 
total content per scaffold.
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The DCC-encapsulated scaffolds contained more hydroxyproline than both the PLGA 
(blank) and TGF scaffolds at day 0 and week 3, even with baseline values subtracted out 
from acellular scaffolds (p<0.001) (Fig. 6). Specifically, the DCC-encapsulated group had 
nearly 7 times as much hydroxyproline as the blank group (p<0.001) and almost 10 times as 
much hydroxyproline as the TGF group (p<0.001) at day 0. At week 3, the DCC-
encapsulated scaffold group contained approximately 8 times the amount of hydroxyproline 
as the TGF scaffolds and 40 times the amount of hydroxyproline as the blank scaffolds 
(p<0.001). At week 6, DCC-encapsulated scaffolds exhibited a significant 70% reduction in 
the amount of hydroxyproline per scaffold (p<0.005), although here was no significant 
change in hydroxyproline content in the DCC-coated scaffolds with time. At week 6, the 
DCC-encapsulated group had over 10 times as much hydroxyproline as the blank group 
(p<0.05) and over 4 times more hydroxyproline than the TGF group (p < 0.05).
In blank, DCC-encapsulated, and DCC-coated cell seeded scaffolds the GAG contents 
significantly decreased from week 3 to week 6 (p<0.001) (Fig. 6). Similar trends were seen 
between GAG and hydroxyproline content, e.g., decreased amount of GAG content at week 
6 compared to week 3. DCC-encapsulated scaffolds had 3 times greater GAG content and 8 
times greater hydroxyproline content at 3 weeks compared to the TGF group at the same 
time (p<0.001). At week 6, the GAG content of the DCC-encapsulated scaffolds decreased 
by 65% from the week 3 value (p<0.005).
Mechanical Testing
The blank, TGF, and DCC-encapsulated scaffolds groups at week 0 had compressive elastic 
moduli around 80 kPa that were not significantly different from one another. However, the 
DCC-coated group compressive elastic modulus was approximately 75% less than all of the 
other groups (p<0.05) (Fig. 7). As a basis of comparison for the DCC-coated group, the acid 
treated scaffolds were not statistically significant from the blank scaffolds or the DCC-
coated scaffolds. The acid treated scaffold compressive elastic modulus was over 3 times 
greater than that of the DCC-Coated scaffolds, however, there was no statistical significance 
between the groups.
Gene Expression
At day 0, the TGF group had a mean value of collagen II gene expression that was over 3 
times higher than the mean value for the DCC-encapsulated group, however, the difference 
was not statistically significant (Fig. 8). The TGF group had nearly 16 times the expression 
of collagen II compared to the blank group at day 0 (p<0.001). There was no statistically 
significant difference between collagen II expression in the DCC-encapsulated group and 
TGF group. The DCC-coated group had significantly less expression than the TGF group at 
day 0 (p<0.001). After day 0, no group showed a detectable expression of collagen II.
At day 0, day 10, and week 3, the DCC-encapsulated group had a similar expression of Sox9 
compared to the blank group. Additionally, the DCC-encapsulated group had similar 
expression of Sox9 as the TGF group at day 10 and week 3. At day 0, the TGF group had 
nearly 3 times the expression of Sox9 compared to the DCC-coated group (p<0.001).
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There were no statistically significant differences in aggrecan expression among groups at 
any time point. However, it was worth noting that the aggrecan expression in the blank 
group decreased 87% at week 3 compared to days 0 and 10 (p<0.01).
Both TGF and DCC-encapsulated groups had nearly 80% less expression of Collagen I at 
day 0 compared to the blank and DCC-coated groups (p<0.001). At day 0, the blank group 
had 2.5 times greater expression of Runx2 compared to the TGF group (p<0.001). There 
were no significant differences among the TGF, DCC-coated, and DCC-encapsulated groups 
with respect to Runx2 expression.
Immunohistochemical Staining
Immunohistochemical staining of week 3 DCC-encapsulated scaffolds was positive for 
collagen II, collagen I, and aggrecan (Fig. 9). Collagen I staining was more intense in the 
cell-seeded DCC-encapsulated scaffolds compared to the acellular DCC-encapsulated 
scaffolds. Collagen II and aggrecan staining were comparable between cell-seeded and 
acellular scaffolds at week 3.
Discussion
In the current study, DCC was incorporated into microsphere-based scaffolds either by 
coating PLGA microsphere scaffold surfaces or by encapsulating the DCC within the PLGA 
microspheres. Although cellular response characterization to the DCC in the microsphere-
based scaffolds did not overwhelmingly indicate chondrogenesis in BMSCs, the DCC 
material did induce some level of bioactivity with the cells. The difference between the 
loading amounts achieved by different DCC incorporation methods (coating vs. 
encapsulating) may have contributed to the difference in cellular responses to the respective 
scaffold types, as the acellular DCC-encapsulated scaffolds contained significantly greater 
amounts of GAG and hydroxyproline than the acellular DCC-coated scaffolds, which may 
be viewed as an inherent limitation in the coating method. Although the processing of the 
DCC material in both DCC-coated and DCC-encapsulated groups was the same, the 
presentation of the material to the BMSCs was different and may have also contributed to 
differences in cell response. The DCC-encapsulated group relied more greatly on diffusion 
of the DCC out of PLGA microspheres and degradation of these microspheres, even though 
there was visible distribution of DCC on the surface of the DCC-encapsulated microspheres 
with SEM-EDS. In contrast, DCC on the DCC-coated group was available for cells on the 
surface of the scaffolds and did not rely on diffusion or degradation.
A benefit to the microsphere-based scaffolds and encapsulation technique used in the study 
was that the DCC-encapsulated scaffolds had comparable mechanical properties to the 
PLGA scaffolds. The DCC-coated scaffolds, however, had a significantly reduced 
compressive modulus compared to all other scaffold types. The decrease in mechanical 
stiffness of the DCC-coated scaffolds may have been partially due to the coating procedure 
and exposure to acid as the acidic conditions could increase the rate of degradation of the 
PLGA. However, the acid-treated scaffolds evaluated for purpose of comparison did not 
exhibit the same decrease in modulus as the DCC-coated scaffolds, meaning some aspect of 
the DCC coating itself may have adversely affected mechanical performance. Previous 
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studies have also reported decreased mechanical properties in cartilage matrix-polymer 
constructs compared to polymer-only constructs.14, 27
The porous morphology of the microspheres allowed for diffusion of DCC out of the 
respective scaffold types. Based on quantification of remaining hydroxyproline and GAG 
content in acellular scaffolds, by week 6, the remaining GAG content reduced by 50% and 
the remaining hydroxyproline content reduced by 75% in the DCC-encapsulated scaffolds. 
At week 6, the total hydroxyproline and GAG content in cell-seeded DCC-encapsulated 
scaffolds also significantly decreased compared to previous time points. Additionally, at 
week 3, chondrogenic markers Sox9, aggrecan, and collagen II all decreased in the DCC-
encapsulated group. The decrease in chondrogenic gene markers at week 3 in the DCC-
encapsulated scaffold group was consistent with the more intense staining of collagen I at 
week 3 in the DCC-encapsulated scaffolds. However, although chondrogenic markers 
decreased at week 3, collagen I and the osteogenic marker Runx2 remained low and not 
significantly different from that of the TGF group. At all gene expression time points, 
although the DCC-encapsulated scaffolds did not differ significantly from the TGF group, 
the hydroxyproline content was greater in DCC-encapsulated constructs at all time points 
compared to the TGF scaffolds. The GAG content was also greater in DCC-encapsulated 
scaffolds than in TGF scaffolds at day 0 and week 3. These higher biochemical contents in 
the DCC-encapsulated group may suggest that the encapsulated DCC was more effective 
than TGF-β at inducing biosynthesis in BMSCs, although there was not sufficient evidence 
of outperforming TGF-β in inducing chondrogenesis. Once less than half of the originally 
encapsulated DCC remained in the scaffolds, a decrease in GAG and hydroxyproline 
production rate was observed as well as a decrease in chondrogenic gene markers. The 
significant reduction in remaining DCC encapsulated within the scaffolds suggests that the 
bioactivity that was observed through week 3 was due to the encapsulated DCC. In vivo, the 
DCC in an osteochondral defect would be better confined to the defect and may thus 
possibly be more potent in its bioactivity, although future studies will be required to evaluate 
this possibility.
The greater cell number as evaluated by DNA content at the initial time point for DCC-
coated than for DCC-encapsulated constructs may be due to the immediate exposure to 
DCC, which may contain cellular adhesion sites to aid in cell attachment and migration. 
Such an advantage with immediate cell response may be of major importance in vivo as 
initial BMSCs infiltrate the scaffold from an osteochondral defect.
The mechanism by which DCC would induce chondrogenesis is still unclear at this time. In 
the current study, we showed that encapsulated DCC and TGF-β had similar effects on 
BMSC gene expression in vitro, but encapsulated DCC had a greater effect on BMSC 
production of GAG and collagen than TGF-β. The encapsulation of DCC compromised the 
macro-structure of the matrix during solubilization and the DCC effect remained positive on 
the cells, this may indicate that the structure of the matrix is not vital to bioactivity induced 
by DCC. Additionally, the difference between the amounts of DCC material each scaffold 
type contained (coated vs. encapsulated) may have had an effect on the differences seen in 
cellular response. The response to DCC may be dose dependent. Additional work to identify 
a preferred loading dose may be beneficial for future work.
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Microsphere-based scaffolds are a promising alternative to current cartilage repair 
techniques due to the ability to control both their mechanical properties and to encapsulate a 
wide variety of materials.8, 12, 26, 32 Encapsulated materials can be selected to aid in stem 
cell differentiation and cartilage tissue repair.26 DCC was chosen for encapsulation and 
coating because of previous studies citing cartilage matrix as a potentially chondroinductive 
material.10, 14, 24, 27, 34 The use of decellularized cartilage instead of native or devitalized 
cartilage is advantageous from clinical and commercial standpoints because of decreased 
immunogenicity and long term storage of the material. Successful decellularization of 
tissues, i.e., complete removal of residual DNA and immunogenic antigens, may also 
eventually lead to safer xenogeneic tissue implants for all tissue types.19, 20, 29
In summary, DCC microsphere-based scaffolds led to gene expression and mechanical 
performance comparable to that of TGF-β, while outperforming both the TGF-β and control 
groups in biosynthesis, suggesting that DCC in a microsphere-based scaffold may indeed be 
bioactive, but additional work remains in terms of method of incorporation (i.e., coated vs. 
encapsulated) and dose to determine whether indeed a chondroinductive approach is 
achievable. Encapsulation of DCC carries the advantage of delivering greater amounts of 
DCC, whereas coating with DCC has the advantages of immediate exposure without relying 
on diffusion or degradation. In terms of the method of incorporation, the DCC-encapsulated 
group generally outperformed the DCC-coated group with the techniques presented. 
However, perhaps a combination of coating and encapsulation to leverage the advantages of 
each would provide the greatest overall effect. Overall, using microsphere-based scaffolds as 
a means to incorporate and deliver DCC to regenerating cartilage may be a powerful tool in 
the future for treatment of cartilage defects.
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SEM images of microsphere morphology. Both TGF-β3- and decellularized cartilage 
(DCC)-encapsulated microspheres had slightly porous surfaces, whereas PLGA 
microspheres (i.e., blank, nothing encapsulated) had smooth surfaces. Scale bars are 100 μm. 
A) PLGA microsphere, B) DCC-encapsulated microsphere, and C) TGF-β3-encapsulated 
microsphere.
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A) Scanning electron microscopy (SEM) image of a representative decellularized cartilage 
(DCC)-encapsulated microsphere, and B) energy dispersive spectroscopy (EDS) pixel map 
depicting the location of atomic nitrogen on the surface of the DCC-encapsulated 
microsphere. Given that the PLGA polymer does not contain atomic nigrogen, it can be seen 
that DCC was distributed across the surface of the microsphere. Scale bars are 10 μm.
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Remaining GAG and hydroxyproline in acellular DCC-encapsulated and DCC-coated 
scaffolds at day 0, week 3 and week 6. All scaffolds exhibited a decrease in biochemical 
content by week 3 (p<0.05). n = 5. Data is reported as mean ± standard deviation. * denotes 
statistical significance from DCC-coated group at the same time point, @ denotes statistical 
significance from the day 0 time point, $ denotes statistical significance from the previous 
time point.
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Relative loss of A) hydroxyproline and B) GAG from acellular DCC-Coated and DCC-
Encapsulated scaffolds. By week 6, a greater proportion of hydroxyproline was lost from the 
DCC-Coated scaffolds and an equal proportion of GAG was lost from each type of scaffold. 
n = 5. Data is reported at mean ± standard deviation. * denotes statistical significance from 
DCC-coated group at the same time point, @ denotes statistical significance from the day 0 
time point, $ denotes statistical significance from the previous time point.
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PicoGreen results depicting greater DNA content on DCC-coated scaffolds at week 0 
(corresponding to 24 hours after seeding). Blank = PLGA microspheres with nothing 
encapsulated, TGF = PLGA microspheres with TGF-β3 encapsulated, DCC-coated = PLGA 
microspheres with nothing encapsulated but coated in decellularized cartilage (DCC), and 
DCC-encapsulated = PLGA microspheres with DCC encapsulated. *denotes statistically 
significant difference from all other groups at same time and subsequent times of same 
group (p<0.05). Data are reported as mean ± standard deviation (n = 5).
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Biochemical contents of engineered constructs (n=5). Note that hydroxyproline and GAG 
contents were measured for acellular scaffolds containing DCC and subtracted out as a 
baseline value. A) Hydroxyproline content on all scaffolds, a decrease in hydroxyproline is 
observed following week 3 on all scaffolds. B) GAG content on all scaffolds, also with a 
decrease in content following week 3. Blank = PLGA microspheres with nothing 
encapsulated, TGF = PLGA microspheres with TGF-β3 encapsulated, DCC-coated = PLGA 
microspheres with nothing encapsulated but coated in decellularized cartilage (DCC), and 
DCC-encapsulated = PLGA microspheres with DCC encapsulated. *denotes statistically 
significant difference from day 0 value, @denotes statistically significant difference from 
blank group at same time point, $denotes statistically significant difference from TGF group 
at same time point, & denotes statistically significant from DCC-Coated at the same time 
point, and + denotes statistically significant difference from DCC at same time point. All 
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significance reported for p<0.05. Data are reported as mean ± standard deviation, and day 0 
corresponds to 24 hours after seeding.
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The compressive elastic moduli of engineered scaffolds prior to cell seeding (n=4-5). The 
DCC-coated scaffolds had significantly lower compressive moduli than the blank, TGF, and 
DCC-encapsulated scaffolds. Blank = PLGA microspheres with nothing encapsulated, TGF 
= PLGA microspheres with TGF-β3 encapsulated, DCC-coated = PLGA microspheres with 
nothing encapsulated but coated in decellularized cartilage (DCC), and DCC-encapsulated = 
PLGA microspheres with DCC encapsulated. *denotes significant difference from blank 
scaffolds (p<0.05) and $denotes significance from DCC-coated scaffolds. Data are reported 
as mean ± standard deviation.
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RT-PCR results for all scaffolds and time points (n=5). A) Collagen II expression was 
significantly greater in TGF scaffolds compared to all others. B) Sox9 expression was 
significantly lower in DCC-coated scaffolds at day 0 compared to all other scaffolds. C) 
Aggrecan expression was nearly equal among all scaffold types during culture. D) Collagen 
I expression was lower in both TGF and DCC-encapsulated scaffolds at day 0. E) Runx2 
expression was greatest in blank scaffolds at day 0. Blank = PLGA microspheres with 
nothing encapsulated, TGF = PLGA microspheres with TGF-β3 encapsulated, DCC-coated 
= PLGA microspheres with nothing encapsulated but coated in decellularized cartilage 
(DCC), and DCC-encapsulated = PLGA microspheres with DCC encapsulated. * denotes 
significant from time 0 value (same group), @ denotes significant from blank at same time 
point, $ denotes significant from TGF at same time point, & denotes significant from DCC-
coated at same time point. For all significance noted (p<0.05). Data are reported as mean ± 
standard deviation, and Day 0 corresponds to 24 hours after seeding.
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Immunohistochemical staining of decellularized cartilage (DCC)-encapsulated scaffolds at 
week 3. Staining was positive for collagen II, collagen I, and aggrecan. Collagen I staining 
was more intense and present between microspheres in the cell-seeded group compared to 
the acellular group. Round objects are intact microspheres, material outside of microspheres 
can be seen in collagen I stained cell-seeded group. Scale bars represent 100 μm.
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